Engineering approaches for studying immune-tumor cell interactions and immunotherapy
Summary: This review describes recent research that has advanced our understanding of the role of immune cells in the tumor microenvironment (TME) using advanced 3D in vitro models and engineering approaches. The TME can hinder effective eradication of tumor cells by the immune system, but immunothe...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004220311822 |
id |
doaj-71c58e95598b4a84a7ea49bab20885c7 |
---|---|
record_format |
Article |
spelling |
doaj-71c58e95598b4a84a7ea49bab20885c72021-01-24T04:28:59ZengElsevieriScience2589-00422021-01-01241101985Engineering approaches for studying immune-tumor cell interactions and immunotherapySarah E. Shelton0Huu Tuan Nguyen1David A. Barbie2Roger D. Kamm3Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USADepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USADepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USADepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Corresponding authorSummary: This review describes recent research that has advanced our understanding of the role of immune cells in the tumor microenvironment (TME) using advanced 3D in vitro models and engineering approaches. The TME can hinder effective eradication of tumor cells by the immune system, but immunotherapy has been able to reverse this effect in some cases. However, patient-to-patient variability in response suggests that we require deeper understanding of the mechanistic interactions between immune and tumor cells to improve response and develop novel therapeutics. Reconstruction of the TME using engineered 3D models allows high-resolution observation of cell interactions while allowing control of conditions such as hypoxia, matrix stiffness, and flow. Moreover, patient-derived organotypic models are an emerging tool for prediction of drug efficacy. This review highlights the importance of modeling and understanding the immune TME and describes new tools for identifying new biological targets, drug testing, and strategies for personalized medicine.http://www.sciencedirect.com/science/article/pii/S2589004220311822Components of the Immune SystemCancerBioengineering |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sarah E. Shelton Huu Tuan Nguyen David A. Barbie Roger D. Kamm |
spellingShingle |
Sarah E. Shelton Huu Tuan Nguyen David A. Barbie Roger D. Kamm Engineering approaches for studying immune-tumor cell interactions and immunotherapy iScience Components of the Immune System Cancer Bioengineering |
author_facet |
Sarah E. Shelton Huu Tuan Nguyen David A. Barbie Roger D. Kamm |
author_sort |
Sarah E. Shelton |
title |
Engineering approaches for studying immune-tumor cell interactions and immunotherapy |
title_short |
Engineering approaches for studying immune-tumor cell interactions and immunotherapy |
title_full |
Engineering approaches for studying immune-tumor cell interactions and immunotherapy |
title_fullStr |
Engineering approaches for studying immune-tumor cell interactions and immunotherapy |
title_full_unstemmed |
Engineering approaches for studying immune-tumor cell interactions and immunotherapy |
title_sort |
engineering approaches for studying immune-tumor cell interactions and immunotherapy |
publisher |
Elsevier |
series |
iScience |
issn |
2589-0042 |
publishDate |
2021-01-01 |
description |
Summary: This review describes recent research that has advanced our understanding of the role of immune cells in the tumor microenvironment (TME) using advanced 3D in vitro models and engineering approaches. The TME can hinder effective eradication of tumor cells by the immune system, but immunotherapy has been able to reverse this effect in some cases. However, patient-to-patient variability in response suggests that we require deeper understanding of the mechanistic interactions between immune and tumor cells to improve response and develop novel therapeutics. Reconstruction of the TME using engineered 3D models allows high-resolution observation of cell interactions while allowing control of conditions such as hypoxia, matrix stiffness, and flow. Moreover, patient-derived organotypic models are an emerging tool for prediction of drug efficacy. This review highlights the importance of modeling and understanding the immune TME and describes new tools for identifying new biological targets, drug testing, and strategies for personalized medicine. |
topic |
Components of the Immune System Cancer Bioengineering |
url |
http://www.sciencedirect.com/science/article/pii/S2589004220311822 |
work_keys_str_mv |
AT saraheshelton engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy AT huutuannguyen engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy AT davidabarbie engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy AT rogerdkamm engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy |
_version_ |
1724326694385352704 |